Clinuvel Pharmaceuticals Stock
Clinuvel Pharmaceuticals Stock
We can see a decrease in the price for Clinuvel Pharmaceuticals. Compared to yesterday it has lost -€0.056 (-1.010%).
Our community identified positive and negative aspects for Clinuvel Pharmaceuticals stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Clinuvel Pharmaceuticals stock. On the other hand our users think that "Customer and product portfolio" could be a problem in the future.
Pros and Cons of Clinuvel Pharmaceuticals in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Clinuvel Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Clinuvel Pharmaceuticals | -1.010% | 1.273% | -10.306% | -4.378% | -21.161% | -54.623% | -70.952% |
| Carbylan Therapeutics Inc | -1.590% | -4.651% | 5.128% | 62.376% | 29.134% | 121.622% | -24.074% |
| Pharma Mar S.A. | -1.090% | 1.264% | 12.799% | 25.221% | 22.392% | 119.390% | -5.286% |
| Mayne Pharma Group Ltd. | 1.670% | 0.000% | -21.053% | -67.914% | -25.926% | -52.381% | 380.000% |
